Prof. Lan Dai

Analytical Development and Quality Control,

Genentech, Inc., USA

Associate Scientist



2011 Ph.D., Bioinformatics, University of Michigan

2004 B.Sc., Biology, Sichuan University

Publications (Selected)

  1. Dai L, Preston R, Bacica M, Kinhikar A, Bolaños B, Murphy R, “The Development of a Potential High-throughput Workflow to Characterize Sites of Bioconjugation by Immuno-affinity Capture Coupled to MALDI-TOF Mass Spectrometry”, Bioconjugate Chemistry, 2013. 24(1): p.53-62.
  2. Dai L, He J, Liu Y, Byun J, Vivekanandan A, Pennathur S, Fan X, Lubman DM, “Dose-Dependent Proteomic Analysis of Glioblastoma Cancer Stem Cells upon Treatment with Gamma-Secretase Inhibitor”, Proteomics,2011. 11(23): p.4529-40.
  3. Dai L, Liu Y, He J, Flack CG, Talsma CE, Crowley JG, Muraszko KM, Fan X, Lubman DM, “Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor”,Proteomics, 2011. 11(20): p.4021-8.
  4. Dai L and Lubman DM, “Development of Micro-scale Sample Preparation and Prefractionation Methods in LC-MS based Shotgun Proteomic Studies”, Chapter 10 inSample Preparation in Biological Mass Spectrometry, Ed. by A.Ivanov and A. Lazarev, Springer, 2011
  5. Dai L, Li C, Shedden KA, Lee CJ, Li C, Quoc H, Simeone DM, Lubman DM, “Quantitative Proteomic Profiling Studies of Pancreatic Cancer Stem Cells”,Journal of Proteome Research, 2010. 9(7): p.3394-402 (Reported by Pancreatic Cell News).
  6. Dai L, Li C, Shedden KA, Misek DE, Lubman DM, “Comparative Proteomic Study of Two Closely-related Ovarian Endometrioid Adenocarcinoma Cell Lines using cIEF Fraction and Pathway Analysis”,Electrophoresis, 2009. 30(7): p.1119-31 (Featured as Cover Story).